Skip to main content
Book cover

Angiogenesis pp 213–221Cite as

Angiogenic Polypeptides in Breast Cancer: Expression of Mrna’s in Primary Human Tumours, MCF-7 Cell Transfection and Xenograft Models

  • Chapter
  • 111 Accesses

Part of the book series: NATO ASI Series ((NSSA,volume 298))

Abstract

Screening of 84 primary human breast carcinomas for the mRNA expression of seven angiogenic polypeptides showed that the most commonly expressed and/or the most highly expressed when compared to normal breast tissue were vascular endothelial growth factor (VEGF) and platelet-derived endothelial cell growth factor/thymidine Phosphorylase (PDECGF/TP)1. The neurokines midkine (MK) and pleiotrophin were also fairly commonly expressed in tumour but not normal tissue (unpublished data from this group and ref. 1).

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Reif M, LeJeune S, Scott PAE, Fox S, Smith K, Leek R, Moghaddam A, Whitehouse R, Bicknell R, Harris AL. Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, transforming growth factor b-1, platelet-derived endothelial cell growth factor, placental growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis. Cancer Res 57:963–969, 1997

    Google Scholar 

  2. O’Brien T, Cranston D, Fuggle S, Bicknell R, Harris AL. The angiogenic factor midkine is expressed in bladder cancer and overexpression correlates with a poor outcome in patients with invasive cancers. Cancer Res 56: 2515–2518, 1996

    PubMed  Google Scholar 

  3. Bicknell R. Mechanistic insights into tumour angiogenesis. in “Tumour Angiogenesis” Ed. Bicknell R, Lewis CE, Ferrara N, pp 19–28, Oxford University Press, 1997

    Google Scholar 

  4. Choudhuri R, Zhang H.T., Donnini S, Ziche M, Bicknell R. An angiogenic role for the neurokines midkine and pleiotrophin in tumourigenesis. Cancer Res 57: 1814–1819, 1997

    CAS  PubMed  Google Scholar 

  5. Zhang HT, Craft P, Scott PAE, Ziche M, Weich HA, Harris AL, Bicknell R. Enhancement of tumour growth and vascular density by transfection of vascular endothelial cell growth factor into MCF-7 human breast carcinoma cells. J Natl Cancer Inst 87: 213–219, 1995

    Article  CAS  PubMed  Google Scholar 

  6. Scott PAE. Vascular endothelial growth factor in breast carcinoma. D. Phil thesis, University of Oxford, 1996

    Google Scholar 

  7. Gasparini G. Prognostic and predictive value of intra-tumoral microvessel density in human solid tumours. In “Tumour Angiogenesis” Ed. Bicknell R, Lewis CE Ferrara N, pp 29–44. Oxford University Press, 1997

    Google Scholar 

  8. Moghaddam A and Bicknell R. Expression of platelet-derived endothelial cell growth factor in E coli and confirmation of its thymidine Phosphorylase activity. Biochemistry, 31: 12141–12146, 1992

    Article  CAS  PubMed  Google Scholar 

  9. Usuki K, Saras J, Waltenberger J, Miyazono K, Pierce G, Thomason A, Heldin CH. Platelet-derived endothelial cell growth factor has thymidine Phosphorylase activity. Biochem Biophys Res Commun 184: 1311–1316, 1992

    Article  CAS  PubMed  Google Scholar 

  10. Finnis C., Dodsworth N, Pollitt CE, Carr G and Sleep D. Thymidine Phosphorylase activity of platelet-derived endothelial cell growth factor is responsible for endothelial cell mitogenicity. Eur J Biochem 212: 201–210, 1993

    Article  CAS  PubMed  Google Scholar 

  11. Griffiths L, Dachs GU, Bicknell R, Harris AL and Stratford IJ. The influence of oxygen tension and pH on the expression of platelet-derived endothelial cell growth factor / thymidine Phosphorylase in human breast tumour cells grown in vitro and in vivo. Cancer Res 57: 570–572, 1997

    CAS  Google Scholar 

  12. Moghaddam A, Zhang HT, Fan TPD, Hu DE, Lees VC, Turley H, Fox SB, Gatter KC, Harris AL, Bicknell R. Thymidine Phosphorylase is angiogenic and promotes tumour growth. Proc Natl Acad Sci USA 92, 998–1002, 1995

    Article  CAS  PubMed  Google Scholar 

  13. Ishikawa F, Miyazono K, Hellman U, Drexler H, Wernstedt C., Hagiwara K et al. Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factors. Nature 338: 557–562, 1989

    Article  CAS  PubMed  Google Scholar 

  14. Moghaddam A, Choudhuri R, Bicknell R. Thymidine phosphorylase/platelet-derived endothelial cell growth factor: an angiogenic factor, in “Tumour Angiogenesis” Ed. Bicknell R, Lewis CE, Ferrara N, pp 251–260, Oxford University Press, 1997

    Google Scholar 

  15. Reynolds K, Farzaneh F, Collins WP, Campbell S, Bourne TH, Lawton F, Moghaddam A, Harris AL, Bicknell R. Association of ovarian malignancy with expression of platelet-derived endothelial cell growth factor. J Natl Cancer Inst 86: 1234–1238, 1994

    Article  CAS  PubMed  Google Scholar 

  16. Fox SB, Westwood M, Moghaddam A, Comley M, Turley H, Whitehouse RM, Bicknell R, Gatter KC, Harris AL. The angiogenic factor platelet-derived endothelial cell growth factor / thymidine Phosphorylase is up-regulated in breast cancer epithelium. Brit J Cancer 73: 275–280, 1996

    Article  CAS  PubMed  Google Scholar 

  17. Takahashi Y, Bucana CD, Liu W, Yoneda J, Kitadai Y, Cleary KR et al. Platelet-derived endothelial cell growth factor in human colon cancer angiogenesis: role of infiltrating cells. J Natl Cancer Inst 88:1146–1151, 1996

    Article  CAS  PubMed  Google Scholar 

  18. Takebayashi Y, Akiyama S, Akiba S, Yamada K, Miyadera K, Sumizawa T et al. Clinicopathologic and prognostic significance of an angiogenic factor, thymidine Phosphorylase, in human colorectal cancer. J Natl Cancer Inst 88: 1110–1117, 1996

    Article  CAS  PubMed  Google Scholar 

  19. Folkman J. What is the role of thymidine Phosphorylase in tumour angiogenesis? J Natl Cancer Inst 88: 1091–1092, 1996

    Article  CAS  PubMed  Google Scholar 

  20. Haraguchi M, Kazutaka M, Uemura K, Sumizawa T, Furukawa T, Yamada K, Akiyama SI. Angiogenic activity of enzymes. Nature 368: 198, 1994

    Article  CAS  PubMed  Google Scholar 

  21. Jagger RT, Bicknell R. Vascular targeting of anti-cancer gene therapy, in “Tumour Angiogenesis” Ed: Bicknell R, Lewis CE, Ferrara N, pp 357–376, Oxford University Press, 1997

    Google Scholar 

  22. Fox SB, Turner GDH, Gatter KC, Harris AL. The increased expression of adhesion molecules ICAM-3 and E- and P-selectins on breast cancer endothelium. J Pathol 177:369–376, 1995

    Article  CAS  PubMed  Google Scholar 

  23. Brown LF, Berse B, Jackman RW, Tognazzi K, Manseau EJ, Dvorak HF, Senger DR. Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas. Am J Pathol 143: 1255–1262, 1993

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer Science+Business Media New York

About this chapter

Cite this chapter

Zhang, HT. et al. (1998). Angiogenic Polypeptides in Breast Cancer: Expression of Mrna’s in Primary Human Tumours, MCF-7 Cell Transfection and Xenograft Models. In: Maragoudakis, M.E. (eds) Angiogenesis. NATO ASI Series, vol 298. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-9185-3_23

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-9185-3_23

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4757-9187-7

  • Online ISBN: 978-1-4757-9185-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics